Schedule 13G ownership disclosure
Agomab Therapeutics NV
COMMON STOCK · CUSIP: JYH220000
Event date: 2026-02-27
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- FMR LLC
Shares: 4,873,680.00 · Class: 10.0%
- Abigail P. Johnson
Shares: 4,873,680.00 · Class: 10.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000315066-26-000646
- Form type
- SCHEDULE 13G
- Filer
- Agomab Therapeutics NV
- CIK
- CIK 2020932
- Filed
- Mar 06, 2026
- Reporting period
- Feb 27, 2026
- Description
- Schedule 13G beneficial ownership